Zevra Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ZVRA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
28 Mar 25	BuyUS$2,352	Corey Watton	Individual	300	US$7.84
19 Mar 25	BuyUS$79,624	John Bode	Individual	10,000	US$7.96
11 Oct 24	BuyUS$3,958	Corey Watton	Individual	500	US$7.92
17 Jul 24	BuyUS$13,540	R. Clifton	Individual	2,000	US$6.77
16 Jul 24	BuyUS$68,065	Thomas Anderson	Individual	10,000	US$6.81
12 Jul 24	BuyUS$58,661	John Bode	Individual	10,000	US$5.87

Insider Trading Volume

Insider Buying: ZVRA insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ZVRA?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	20,858	0.0381%
Individual Insiders	3,578,281	6.54%
Hedge Funds	7,789,593	14.2%
General Public	16,487,229	30.2%
Institutions	26,803,680	49%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 30.6%.

Top Shareholders

Top 25 shareholders own 62.86% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.57%	Woodline Partners LP	4,139,593	US$34.9m	2.25%	0.23%
7.55%	BlackRock, Inc.	4,126,563	US$34.8m	1.13%	no data
6.68%	Adage Capital Management, L.P.	3,650,000	US$30.8m	462%	0.05%
5.53%	Samuel Braun	3,021,660	US$25.5m	0%	no data
5.17%	The Vanguard Group, Inc.	2,825,845	US$23.8m	0.06%	no data
4.28%	Nantahala Capital Management, LLC	2,340,333	US$19.7m	-20%	1.36%
4.22%	FMR LLC	2,306,045	US$19.4m	-1%	no data
2.63%	Aigh Capital Management, LLC	1,438,109	US$12.1m	82.4%	5.46%
2.35%	Altium Capital Management LP	1,287,333	US$10.9m	-30.4%	28.63%
2.26%	Geode Capital Management, LLC	1,233,111	US$10.4m	3.79%	no data
2.24%	683 Capital Management, LLC	1,225,834	US$10.3m	0.07%	1.03%
2.14%	State Street Global Advisors, Inc.	1,172,556	US$9.9m	51.7%	no data
1.6%	J. Goldman & Co., L.P.	875,815	US$7.4m	-11%	0.25%
1.25%	Readystate Asset Management LP	683,032	US$5.8m	925%	0.53%
1.13%	Rubric Capital Management LP	616,123	US$5.2m	2,980%	0.09%
1.09%	Stonepine Capital Management LLC	597,700	US$5.0m	-14.6%	2.04%
0.78%	Northern Trust Global Investments	429,111	US$3.6m	-1.57%	no data
0.62%	The Retirement Planning Company of New England, Inc.	338,902	US$2.9m	-34.2%	0.68%
0.62%	Mystic Asset Management, Inc.	338,902	US$2.9m	8.16%	0.68%
0.57%	Stratos Wealth Partners, Ltd	310,000	US$2.6m	-7.69%	0.04%
0.55%	Velan Capital Partners LP	300,000	US$2.5m	50%	3.04%
0.54%	Ikarian Capital, LLC	292,772	US$2.5m	0%	0.87%
0.53%	Barclays PLC Private Banking & Investment Banking Investment	289,688	US$2.4m	403%	no data
0.51%	Janney Montgomery Scott LLC, Asset Management Arm	280,534	US$2.4m	-5.67%	0.01%
0.46%	Morgan Stanley, Investment Banking and Brokerage Investments	251,686	US$2.1m	105%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/16 19:10
End of Day Share Price	2025/05/16 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Zevra Therapeutics, Inc. is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Sumant Satchidanand Kulkarni	Canaccord Genuity
Dewey Steadman	Canaccord Genuity
Kristen Kluska	Cantor Fitzgerald & Co.